Clinical Trial Update: Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to assess the safety and efficacy of Fufang Congrong Yizhi Capsules for cognitive impairment after intracerebral hemorrha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Intracerebral Hemorrhage

Drugs mentioned

• Fufang Congrong Yizhi Capsules (Fufang Congrong Yizhi Capsule)

Snippet

Sponsor: Qinhuangdao Hospital of Traditional Chinese Medicine | Conditions: Cognitive Impairment, Intracerebral Hemorrhage | Phase 4 | Status: RECRUITING